{
    "@context": "https://schema.org",
    "@type": "Article",
    "headline": "Questions to Consider as Regulators Increase Scrutiny of Medical Debt",
    "url": "https://www.lexblog.com/2023/09/27/questions-to-consider-as-regulators-increase-scrutiny-of-medical-debt/",
    "identifier": {
        "@type": "PropertyValue",
        "name": "LexBlog Library record",
        "value": "LEX-WK-VSE6CCKY",
        "url": "https://www.lexblog.com/lib/VSE6CCKY/"
    },
    "datePublished": "2023-09-27T13:29:52-04:00",
    "dateModified": "2023-09-27T10:37:31-04:00",
    "author": {
        "@type": "Person",
        "name": "R. Aaron Chastain, Lee Gilley, Daniel F. Murphy, Bradley"
    },
    "sourceOrganization": {
        "@type": "Organization",
        "name": "Bradley Arant Boult Cummings LLP"
    },
    "organizationScope": "at-publication",
    "isPartOf": "Financial Services Perspectives",
    "about": "Administrative and Regulatory · Health Care and Life Sciences",
    "sourceUrl": "https://www.financialservicesperspectives.com/?p=4610",
    "sourceStability": "may-move"
}